Emerging Cancer Vaccines
Emerging Cancer Vaccines market is segmented by region (country), players, by Type and by Applica ... Read More
1 Study Coverage 1.1 Gene Editing Technologies Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Introduction 1.2 Global Gene Editing Technologies Outlook 2017 VS 2022 VS 2028 1.2.1 Global Gene Editing Technologies Market Size for the Year 2017-2028 1.2.2 Global Gene Editing Technologies Market Size for the Year 2017-2028 1.3 Gene Editing Technologies Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Gene Editing Technologies in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Gene Editing Technologies Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Gene Editing Technologies Market Dynamics 1.4.1 Gene Editing Technologies Industry Trends 1.4.2 Gene Editing Technologies Market Drivers 1.4.3 Gene Editing Technologies Market Challenges 1.4.4 Gene Editing Technologies Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Gene Editing Technologies by Type 2.1 Gene Editing Technologies Market Segment by Type 2.1.1 Double Strand Break Repair 2.1.2 Engineered Nucleases 2.1.3 Clustered Regularly Interspaced Short Palindromic Repeats 2.2 Global Gene Editing Technologies Market Size by Type (2017, 2022 & 2028) 2.3 Global Gene Editing Technologies Market Size by Type (2017-2028) 2.4 United States Gene Editing Technologies Market Size by Type (2017, 2022 & 2028) 2.5 United States Gene Editing Technologies Market Size by Type (2017-2028) 3 Gene Editing Technologies by Application 3.1 Gene Editing Technologies Market Segment by Application 3.1.1 Gene Therapy 3.1.2 Eradicating Diseases 3.2 Global Gene Editing Technologies Market Size by Application (2017, 2022 & 2028) 3.3 Global Gene Editing Technologies Market Size by Application (2017-2028) 3.4 United States Gene Editing Technologies Market Size by Application (2017, 2022 & 2028) 3.5 United States Gene Editing Technologies Market Size by Application (2017-2028) 4 Global Gene Editing Technologies Competitor Landscape by Company 4.1 Global Gene Editing Technologies Market Size by Company 4.1.1 Top Global Gene Editing Technologies Companies Ranked by Revenue (2021) 4.1.2 Global Gene Editing Technologies Revenue by Player (2017-2022) 4.2 Global Gene Editing Technologies Concentration Ratio (CR) 4.2.1 Gene Editing Technologies Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Editing Technologies in 2021 4.2.3 Global Gene Editing Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Gene Editing Technologies Headquarters, Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Type 4.3.1 Global Gene Editing Technologies Headquarters and Area Served 4.3.2 Global Gene Editing Technologies Companies Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Gene Editing Technologies Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Gene Editing Technologies Market Size by Company 4.5.1 Top Gene Editing Technologies Players in United States, Ranked by Revenue (2021) 4.5.2 United States Gene Editing Technologies Revenue by Players (2020, 2021 & 2022) 5 Global Gene Editing Technologies Market Size by Region 5.1 Global Gene Editing Technologies Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Gene Editing Technologies Market Size by Region (2017-2028) 5.2.1 Global Gene Editing Technologies Market Size by Region: 2017-2022 5.2.2 Global Gene Editing Technologies Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Gene Editing Technologies Market Size YoY Growth 2017-2028 6.1.2 North America Gene Editing Technologies Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Gene Editing Technologies Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Gene Editing Technologies Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Gene Editing Technologies Market Size YoY Growth 2017-2028 6.3.2 Europe Gene Editing Technologies Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Gene Editing Technologies Market Size YoY Growth 2017-2028 6.4.2 Latin America Gene Editing Technologies Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Gene Editing Technologies Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Gene Editing Technologies Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Thermo Fisher Scientific 7.1.1 Thermo Fisher Scientific Company Details 7.1.2 Thermo Fisher Scientific Business Overview 7.1.3 Thermo Fisher Scientific Gene Editing Technologies Introduction 7.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2017-2022) 7.1.5 Thermo Fisher Scientific Recent Development 7.2 Merck 7.2.1 Merck Company Details 7.2.2 Merck Business Overview 7.2.3 Merck Gene Editing Technologies Introduction 7.2.4 Merck Revenue in Gene Editing Technologies Business (2017-2022) 7.2.5 Merck Recent Development 7.3 Sangamo Therapeutics 7.3.1 Sangamo Therapeutics Company Details 7.3.2 Sangamo Therapeutics Business Overview 7.3.3 Sangamo Therapeutics Gene Editing Technologies Introduction 7.3.4 Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2017-2022) 7.3.5 Sangamo Therapeutics Recent Development 7.4 Lonza 7.4.1 Lonza Company Details 7.4.2 Lonza Business Overview 7.4.3 Lonza Gene Editing Technologies Introduction 7.4.4 Lonza Revenue in Gene Editing Technologies Business (2017-2022) 7.4.5 Lonza Recent Development 7.5 Transposagen Biopharmaceuticals 7.5.1 Transposagen Biopharmaceuticals Company Details 7.5.2 Transposagen Biopharmaceuticals Business Overview 7.5.3 Transposagen Biopharmaceuticals Gene Editing Technologies Introduction 7.5.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2017-2022) 7.5.5 Transposagen Biopharmaceuticals Recent Development 7.6 Editas Medicine 7.6.1 Editas Medicine Company Details 7.6.2 Editas Medicine Business Overview 7.6.3 Editas Medicine Gene Editing Technologies Introduction 7.6.4 Editas Medicine Revenue in Gene Editing Technologies Business (2017-2022) 7.6.5 Editas Medicine Recent Development 7.7 CRISPR Therapeutics 7.7.1 CRISPR Therapeutics Company Details 7.7.2 CRISPR Therapeutics Business Overview 7.7.3 CRISPR Therapeutics Gene Editing Technologies Introduction 7.7.4 CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2017-2022) 7.7.5 CRISPR Therapeutics Recent Development 7.8 Agilent Technologies 7.8.1 Agilent Technologies Company Details 7.8.2 Agilent Technologies Business Overview 7.8.3 Agilent Technologies Gene Editing Technologies Introduction 7.8.4 Agilent Technologies Revenue in Gene Editing Technologies Business (2017-2022) 7.8.5 Agilent Technologies Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Gene Editing Technologies Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Gene Editing Technologies Market Trends Table 3. Gene Editing Technologies Market Drivers Table 4. Gene Editing Technologies Market Challenges Table 5. Gene Editing Technologies Market Restraints Table 6. Global Gene Editing Technologies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Gene Editing Technologies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Gene Editing Technologies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Gene Editing Technologies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Gene Editing Technologies Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Gene Editing Technologies Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Gene Editing Technologies Revenue Share by Player, 2017-2022 Table 13. Global Gene Editing Technologies Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Gene Editing Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Technologies as of 2021) Table 15. Top Players of Gene Editing Technologies in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Gene Editing Technologies Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Gene Editing Technologies Players in United States Market, Ranking by Revenue (2021) Table 20. United States Gene Editing Technologies Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Gene Editing Technologies Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Gene Editing Technologies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Gene Editing Technologies Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Gene Editing Technologies Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Gene Editing Technologies Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Gene Editing Technologies Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Gene Editing Technologies Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Gene Editing Technologies Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Gene Editing Technologies Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Thermo Fisher Scientific Company Details Table 31. Thermo Fisher Scientific Business Overview Table 32. Thermo Fisher Scientific Gene Editing Technologies Product Table 33. Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 34. Thermo Fisher Scientific Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Gene Editing Technologies Product Table 38. Merck Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. Sangamo Therapeutics Company Details Table 41. Sangamo Therapeutics Business Overview Table 42. Sangamo Therapeutics Gene Editing Technologies Product Table 43. Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 44. Sangamo Therapeutics Recent Development Table 45. Lonza Company Details Table 46. Lonza Business Overview Table 47. Lonza Gene Editing Technologies Product Table 48. Lonza Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 49. Lonza Recent Development Table 50. Transposagen Biopharmaceuticals Company Details Table 51. Transposagen Biopharmaceuticals Business Overview Table 52. Transposagen Biopharmaceuticals Gene Editing Technologies Product Table 53. Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 54. Transposagen Biopharmaceuticals Recent Development Table 55. Editas Medicine Company Details Table 56. Editas Medicine Business Overview Table 57. Editas Medicine Gene Editing Technologies Product Table 58. Editas Medicine Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 59. Editas Medicine Recent Development Table 60. CRISPR Therapeutics Company Details Table 61. CRISPR Therapeutics Business Overview Table 62. CRISPR Therapeutics Gene Editing Technologies Product Table 63. CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 64. CRISPR Therapeutics Recent Development Table 65. Agilent Technologies Company Details Table 66. Agilent Technologies Business Overview Table 67. Agilent Technologies Gene Editing Technologies Product Table 68. Agilent Technologies Revenue in Gene Editing Technologies Business (2017-2022) & (US$ Million) Table 69. Agilent Technologies Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Gene Editing Technologies Product Picture Figure 2. Global Gene Editing Technologies Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Gene Editing Technologies Market Size 2017-2028 (US$ Million) Figure 4. United States Gene Editing Technologies Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Gene Editing Technologies Market Size 2017-2028 (US$ Million) Figure 6. United States Gene Editing Technologies Market Share in Global 2017-2028 Figure 7. Gene Editing Technologies Report Years Considered Figure 8. Product Picture of Double Strand Break Repair Figure 9. Product Picture of Engineered Nucleases Figure 10. Product Picture of Clustered Regularly Interspaced Short Palindromic Repeats Figure 11. Global Gene Editing Technologies Market Share by Type in 2022 & 2028 Figure 12. Global Gene Editing Technologies Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Gene Editing Technologies Market Share by Type (2017-2028) Figure 14. United States Gene Editing Technologies Market Share by Type in 2022 & 2028 Figure 15. United States Gene Editing Technologies Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Gene Editing Technologies Market Share by Type (2017-2028) Figure 17. Product Picture of Gene Therapy Figure 18. Product Picture of Eradicating Diseases Figure 19. Global Gene Editing Technologies Market Share by Application in 2022 & 2028 Figure 20. Global Gene Editing Technologies Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Gene Editing Technologies Market Share by Application (2017-2028) Figure 22. United States Gene Editing Technologies Market Share by Application in 2022 & 2028 Figure 23. United States Gene Editing Technologies Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Gene Editing Technologies Market Share by Application (2017-2028) Figure 25. North America Gene Editing Technologies Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Gene Editing Technologies Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Gene Editing Technologies Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Gene Editing Technologies Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Gene Editing Technologies Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Gene Editing Technologies Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 54. Merck Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 55. Sangamo Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 56. Lonza Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 57. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 58. Editas Medicine Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 59. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 60. Agilent Technologies Revenue Growth Rate in Gene Editing Technologies Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed
Thermo Fisher Scientific Merck Sangamo Therapeutics Lonza Transposagen Biopharmaceuticals Editas Medicine CRISPR Therapeutics Agilent Technologies
Emerging Cancer Vaccines market is segmented by region (country), players, by Type and by Applica ... Read More
Genetic Modification market is segmented by region (country), players, by Type and by Application ... Read More
Nanoengineered Surfaces market is segmented by region (country), players, by Type and by Applicat ... Read More
Tactile and Dimensional Printing market is segmented by region (country), players, by Type and by ... Read More